DFE Pharma

DFE Pharma

Arzneimittelherstellung

Your medicines, our solutions. Moving to a healthier world.

Info

DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives. We are driven by our purpose your medicines, our solutions. Moving to a healthier world. Learn more at www.dfepharma.com

Branche
Arzneimittelherstellung
Größe
201–500 Beschäftigte
Hauptsitz
Goch
Art
Privatunternehmen
Spezialgebiete
Excipients

Orte

Beschäftigte von DFE Pharma

Updates

  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    We’re excited to connect at CPHI Milan from 8th to 10th October! Visit us at Booth #6D42 (Excipients hall), where our team of experts will be available to collaborate and support your drug formulation projects with high-quality excipients. Oral Solid Dosage (OSD): ✔ Lactose ✔Microcrystalline Cellulose (MCC) ✔Croscarmellose Sodium ✔Sodium Starch Glycolate ✔Starches Dry Powder Inhalation (DPI): ✔Lactose Biopharma: ✔Sucrose ✔Trehalose Book a meeting: https://lnkd.in/dbfDYiwx

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    Our North America team is ready to meet you and support with your formulation challenges, visit them at our upcoming events: - American Association of Pharmaceutical Scientists (AAPS) | @aapscomms PharmSci, 360. October 20 - 23rd - PODD: October 28 - 29th - SupplySide West 2024: October 28th - 31st Schedule a meeting with our experts: Justin Murrell Mark Wagner Sergio Hernandez Wendy Weinstein Wesley Hardy

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    We are thrilled to announce the publication of a new research paper by our experts, in collaboration with Ghent University, and GEA Group : Understanding Powder Behavior in Continuous Feeding: Powder Densification and Screw Layering. This cutting-edge work addresses real-world challenges in continuous pharmaceutical manufacturing. By combining material science and big data analysis, we present a holistic solution for optimizing continuous powder feeding. Key takeaways: - Methodologies for assessing densification and screw layering during continuous feeding. - Informs the selection of excipients to prevent feeding issues like densification and screw layering. - Strategies for reducing startup times and achieving reliable, long-term feeder operation. - Exploration of co-processed excipients in continuous manufacturing. We’re proud to contribute to advancing the field and would be happy to discuss how these findings can benefit your processes. Reach out to us for more insights. Authors: Sara Fathollahi, Pauline van der Wijst - Janssen, Bram Bekaert, Dirk Vanderroost, Valérie Vanhoorne and Bastiaan HJ Dickhoff. Published in Powders Journal Read the full research paper here: https://lnkd.in/dSPMDCrq

  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    We are excited to announce the nominees for the DFE Pharma Distributor of the Year Award 2024! This award recognizes the outstanding efforts of our global partners in promoting our products and providing excellent service to customers across the world.   A huge congratulations to Quimidroga (Spain), IMCD Group (USA), and Euro Chemo-Pharma (Malaysia) for being selected as this year’s top three distributors. Your dedication and support are invaluable to our success.   Thank you for your continued partnership and commitment to delivering DFE Pharma’s solutions to our customers. The winner will be announced next Monday – stay tuned!

  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    We welcome Mark Wagner as our new Biopharma Sales Manager for the North American Market. Mark is dedicated to delivering tailored solutions that truly meet clients' needs, ensuring practical and impactful results. With extensive experience in biopharmaceuticals, emerging biotechnology, and raw materials, Mark brings a wealth of knowledge to every project. Outside of work, Mark is an avid traveler and hiker who cherishes his roots, maintaining the farm he grew up on and keeping honeybees. His adventurous spirit and passion for exploration make him a fantastic addition to our team. Welcome aboard, Mark!

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    This World Cleanup Day, we are proud to reaffirm our commitment to reducing waste and contributing to a healthier planet. In 2023, we furthered our zero waste to landfill target by increasing the recycling of waste materials and further work improving packaging for sustainability. We have continued our work with our suppliers to ensure that up to 90% of our packaging materials support convenient separation for recycling. Our journey doesn’t stop here. In 2024, DFE Pharma is committed to: • Further improvement of zero waste to landfill by 2025 by better segregation of waste and reduction initiatives • Increasing community involvement and encouraging employees from across the world to participate in environmental projects We believe even the smallest action can make a huge difference. Let's continue working together to create a cleaner, more sustainable future!

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von DFE Pharma anzeigen, Grafik

    25.363 Follower:innen

    Dr. Sara Fathollahi delivered an impressive demonstration at ECCPM on how the right excipient choices can enhance product consistency. Her presentation focused on the impact of material properties on tablet quality in continuous direct compression lines. Additionally, the discussions on the regulatory perspective regarding continuous manufacturing were eye-opening. Engaging early with regulators on novel technologies ensures mutual understanding of the processes, potential risks, and strategies for effective evaluation and mitigation. Aligned with this regulatory approach, we are ready to support your continuous manufacturing activities and help de-risk your excipient choices. Let’s collaborate to drive innovation forward. #Excipients #Pharmaceuticals #ContinuousManufacturing

    • Kein Alt-Text für dieses Bild vorhanden

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen

Finanzierung